glp-1 novo nordisk products Company of the year 2023: – Riding the semaglutide wave Novo Nordisk CEO explains why

Feb 24, 2026 Three hundred million dollars

Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization

Meanwhile, as this segment of the population focuses on themselves, Circana uncovered a decline in many pet segments outside of pet food. Circana also found that certain retail channels resonate with GLP-1 users, as their spending tends to shift away from mass and dollar stores and toward club stores and e-commerce retailers during their first year of active usage of the medication

The authors conclude: In this real-world study where half of patients discontinued GLP-1-based treatment within a year after initiation, not losing weight was associated with worse clinical outcomes while larger reductions were associated with decreased risks

The gutbrain axis enables bidirectional communication between the brain and the gastrointestinal system, involving neuroendocrine pathways, the vagus nerve, immune factors, and microbiota (Carabotti et al., 2015